# Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

> **NCT00385658** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 75 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Fluvastatin extended release, fenofibrate
- **DRUG:** Fixed combination simvastatin/ezetimibe

## Key facts

- **NCT ID:** NCT00385658
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385658, "Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00385658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*